These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 35910883)

  • 1. Model-Based Evaluation of Transmissibility and Intervention Measures for a COVID-19 Outbreak in Xiamen City, China.
    Liu W; Guo Z; Abudunaibi B; Ouyang X; Wang D; Yang T; Deng B; Huang J; Zhao B; Su Y; Su C; Chen T
    Front Public Health; 2022; 10():887146. PubMed ID: 35910883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the effectiveness of measures to control the novel coronavirus disease 2019 in Jilin Province, China.
    Zhao Q; Wang Y; Yang M; Li M; Zhao Z; Lu X; Shen B; Luan B; Zhao Y; Cao B; Yao L; Zhao B; Su Y; Chen T
    BMC Infect Dis; 2021 Mar; 21(1):245. PubMed ID: 33676420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
    Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
    Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Li W; Gong J; Zhou J; Zhang L; Wang D; Li J; Shi C; Fan H
    Epidemiol Infect; 2021 Jan; 149():e2. PubMed ID: 33413715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus disease 2019 outbreak in Beijing's Xinfadi Market, China: a modeling study to inform future resurgence response.
    Wang XL; Lin X; Yang P; Wu ZY; Li G; McGoogan JM; Jiao ZT; He XJ; Li SQ; Shi HH; Wang JY; Lai SJ; Huang C; Wang QY
    Infect Dis Poverty; 2021 May; 10(1):62. PubMed ID: 33962683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimal spatially-dependent control measures to effectively and economically eliminate emerging infectious diseases.
    Xia F; Xiao Y; Ma J
    PLoS Comput Biol; 2024 Oct; 20(10):e1012498. PubMed ID: 39374303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The time-varying transmission dynamics of COVID-19 and synchronous public health interventions in China.
    Xiao J; Hu J; He G; Liu T; Kang M; Rong Z; Lin L; Zhong H; Huang Q; Deng A; Zeng W; Tan X; Zeng S; Zhu Z; Li J; Gong D; Wan D; Chen S; Guo L; Li Y; Li Y; Sun L; Liang W; Song T; He J; Ma W
    Int J Infect Dis; 2021 Feb; 103():617-623. PubMed ID: 33181330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective prediction of the epidemic trend of COVID-19 in Wuhan at four phases.
    Li M; Guo X; Wang X
    J Med Virol; 2021 Apr; 93(4):2493-2498. PubMed ID: 33415760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can ship travel contain COVID-19 outbreak after re-opening: a Bayesian meta-analysis.
    Hsu CY; Chen JK; Wikramaratna PS; Yen AM; Chen SL; Chen HH; Lai CC
    Epidemiol Infect; 2023 May; 151():e99. PubMed ID: 37226697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiological characteristics and effectiveness of countermeasures to contain coronavirus disease 2019 in Ningbo City, Zhejiang Province, China.
    Lao X; Luo L; Lei Z; Fang T; Chen Y; Liu Y; Ding K; Zhang D; Wang R; Zhao Z; Rui J; Zhu Y; Xu J; Wang Y; Yang M; Yi B; Chen T
    Sci Rep; 2021 May; 11(1):9545. PubMed ID: 33953243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. China's Fight Against COVID-19: What We Have Done and What We Should Do Next?
    Cheng S; Zhao Y; Kaminga AC; Zhang X; Xu H
    Front Public Health; 2022; 10():548056. PubMed ID: 35844877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.
    Niu Y; Luo L; Yang S; Abudurusuli G; Wang X; Zhao Z; Rui J; Li Z; Deng B; Liu W; Zhang Z; Li K; Liu C; Li P; Huang J; Yang T; Wang Y; Chen T; Li Q
    Front Public Health; 2022; 10():949594. PubMed ID: 36187650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling outbreaks of COVID-19 in China: The impact of vaccination and other control measures on curbing the epidemic.
    Zha W; Ni H; He Y; Kuang W; Zhao J; Fu L; Dai H; Lv Y; Zhou N; Yang X
    Hum Vaccin Immunother; 2024 Dec; 20(1):2338953. PubMed ID: 38658178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission dynamics and successful control measures of SARS-CoV-2 in the mega-size city of Guangzhou, China.
    Zhao H; Zhang Z; Lun W; Chen Z; Lu X; Li J; Qiu F; Li S; Mao C; Lu Y; Chen J; He Q; Lu J; Yang Z
    Medicine (Baltimore); 2021 Dec; 100(48):e27846. PubMed ID: 35049185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the reproductive number and the outbreak size of COVID-19 in Korea.
    Choi S; Ki M
    Epidemiol Health; 2020; 42():e2020011. PubMed ID: 32164053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission dynamics of the COVID-19 epidemic in England.
    Liu Y; Tang JW; Lam TTY
    Int J Infect Dis; 2021 Mar; 104():132-138. PubMed ID: 33359440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracing day-zero and forecasting the COVID-19 outbreak in Lombardy, Italy: A compartmental modelling and numerical optimization approach.
    Russo L; Anastassopoulou C; Tsakris A; Bifulco GN; Campana EF; Toraldo G; Siettos C
    PLoS One; 2020; 15(10):e0240649. PubMed ID: 33125393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of control measures during the 2022 COVID-19 outbreak in Shanghai, China.
    Hu L; Shi M; Li M; Ma J
    PLoS One; 2023; 18(5):e0285937. PubMed ID: 37200400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.